IPD meta-analysis of 46 RCTs (285,124 participants): each 5 mm Hg systolic reduction lowered major cardiovascular events similarly with CKD (HR 0.91) and without (HR 0.90), across CKD stages 1–5, but less with CKD plus diabetes (HR 0.96).
Meta-analysisn = 285,124
Zeng et al. Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis